Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 4,500 | 2,730 | 2,894 | 738 | 1,509 |
| Cost of Goods | 3,398 | 1,795 | 2,268 | 521 | 684 |
| Gross Profit | 1,102 | 935 | 626 | 217 | 825 |
| Operating Expenses | 7,446 | 6,925 | 11,310 | 6,488 | 5,265 |
| Operating Income | -5,946 | -5,195 | -10,416 | -5,750 | -3,756 |
| Interest Expense | 2,285 | 1,985 | 1,216 | 593 | 601 |
| Other Income | 6,592 | -3,569 | -5,464 | -7,459 | 445 |
| Pre-tax Income | -1,639 | -10,749 | -17,096 | -13,802 | -3,912 |
| Net Income Continuous | -1,639 | -10,749 | -17,096 | -13,802 | -3,912 |
| Net Income | $-1,639 | $-10,749 | $-17,096 | $-13,802 | $-3,912 |
| EPS Basic Total Ops | -2.36 | -8.48 | -14.21 | -10.94 | -3.13 |
| EPS Basic Continuous Ops | -1.28 | -8.48 | -13.60 | -10.94 | -3.13 |
| EPS Diluted Total Ops | -2.67 | -8.48 | -14.21 | -10.94 | -3.13 |
| EPS Diluted Continuous Ops | -1.22 | -8.48 | -13.60 | -10.94 | -3.13 |
| EBITDA(a) | $-5,774 | $-5,011 | $-10,250 | $-5,591 | $-3,612 |